1. Home
  2. SQFT vs ENSC Comparison

SQFT vs ENSC Comparison

Compare SQFT & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQFT
  • ENSC
  • Stock Information
  • Founded
  • SQFT 1999
  • ENSC 2003
  • Country
  • SQFT United States
  • ENSC United States
  • Employees
  • SQFT N/A
  • ENSC N/A
  • Industry
  • SQFT Real Estate Investment Trusts
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQFT Real Estate
  • ENSC Health Care
  • Exchange
  • SQFT Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • SQFT 8.1M
  • ENSC 7.9M
  • IPO Year
  • SQFT 2020
  • ENSC N/A
  • Fundamental
  • Price
  • SQFT $0.61
  • ENSC $4.60
  • Analyst Decision
  • SQFT
  • ENSC
  • Analyst Count
  • SQFT 0
  • ENSC 0
  • Target Price
  • SQFT N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • SQFT 23.3K
  • ENSC 13.3K
  • Earning Date
  • SQFT 03-18-2025
  • ENSC 03-18-2025
  • Dividend Yield
  • SQFT N/A
  • ENSC N/A
  • EPS Growth
  • SQFT N/A
  • ENSC N/A
  • EPS
  • SQFT N/A
  • ENSC N/A
  • Revenue
  • SQFT $18,586,052.00
  • ENSC $5,210,031.00
  • Revenue This Year
  • SQFT N/A
  • ENSC $89.78
  • Revenue Next Year
  • SQFT N/A
  • ENSC N/A
  • P/E Ratio
  • SQFT N/A
  • ENSC N/A
  • Revenue Growth
  • SQFT 5.44
  • ENSC 40.41
  • 52 Week Low
  • SQFT $0.47
  • ENSC $2.12
  • 52 Week High
  • SQFT $1.39
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • SQFT 40.86
  • ENSC 32.08
  • Support Level
  • SQFT $0.62
  • ENSC $4.85
  • Resistance Level
  • SQFT $0.65
  • ENSC $5.72
  • Average True Range (ATR)
  • SQFT 0.03
  • ENSC 0.37
  • MACD
  • SQFT 0.00
  • ENSC -0.00
  • Stochastic Oscillator
  • SQFT 14.29
  • ENSC 5.18

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: